Generally tend to agree with your analysis here. I did my Base/Covid split at the EBITDA line as the depreciation charge doesn't seem to be influenced that much by the Base/Covid revenue mix. Using some pretty soft assumptions for H2 a $1.0B EBIT figure for the full year seems reasonable. However, do your own research and form your own views.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
Generally tend to agree with your analysis here. I did my...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHL (ASX) to my watchlist
|
|||||
Last
$26.53 |
Change
-0.320(1.19%) |
Mkt cap ! $12.74B |
Open | High | Low | Value | Volume |
$26.90 | $26.91 | $26.31 | $22.77M | 859.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1765 | $26.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$26.53 | 2458 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1539 | 26.520 |
1 | 35 | 26.420 |
1 | 6000 | 26.380 |
1 | 4148 | 26.350 |
3 | 4436 | 26.330 |
Price($) | Vol. | No. |
---|---|---|
26.550 | 958 | 1 |
26.560 | 863 | 1 |
26.570 | 749 | 1 |
26.580 | 777 | 1 |
26.640 | 2000 | 1 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
SHL (ASX) Chart |